相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
Irene Gullo et al.
GASTRIC CANCER (2019)
Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications
Irene Gullo et al.
PATHOBIOLOGY (2018)
Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features
Erika Hissong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Safety and efficacy of nivolumab in the treatment of cancers: A meta-analysis of 27 prospective clinical trials
Yan Tie et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona
Alexander Baraniskin et al.
EUROPEAN JOURNAL OF CANCER (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
Yanhua Wu et al.
ONCOTARGET (2017)
Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity
Charny Park et al.
ONCOIMMUNOLOGY (2017)
The novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?
Christine Boeger et al.
ONCOIMMUNOLOGY (2017)
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project
Bo Hwa Sohn et al.
CLINICAL CANCER RESEARCH (2017)
KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer.
Charles S. Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
Christine Boeger et al.
ONCOTARGET (2016)
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
Sarah Derks et al.
ONCOTARGET (2016)
Immunotherapy for Gastroesophageal Cancer
Emily F. Goode et al.
JOURNAL OF CLINICAL MEDICINE (2016)
CheckMate-032: Phase I/II open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (GC)
Yelena Yuriy Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer
Kakoli Das et al.
ESMO OPEN (2016)
Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples
Margaret H. Veldman-Jones et al.
CANCER RESEARCH (2015)
Deregulation of Immune Response Genes in Patients With Epstein-Barr Virus-Associated Gastric Cancer and Outcomes
Sun Young Kim et al.
GASTROENTEROLOGY (2015)
Update on Epstein-Barr virus and gastric cancer
Aya Shinozaki-Ushiku et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
Ismael Riquelme et al.
ONCOTARGET (2015)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Causes and consequences of microsatellite instability in gastric carcinogenesis
Sergia Velho et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy
Michael J. Strong et al.
PLOS PATHOGENS (2013)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis
Enrico Solcia et al.
VIRCHOWS ARCHIV (2009)
Lymphocyte-rich gastric cancer: Associations with Epstein-Barr virus, microsatellite instability, histology, and survival
KL Grogg et al.
MODERN PATHOLOGY (2003)
The role of histological investigation in prognostic evaluation of advanced gastric cancer - Analysis of histological structure and molecular changes compared with invasive pattern and stage
AM Chiaravalli et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
分享论文
